Use Cases

Make confident investment decisions in early-stage biotech companies by accurately predicting clinical trial outcomes before results are announced. Identify promising assets and avoid costly failures.

• Evaluate portfolio companies' clinical programs with 95% accuracy
• Identify red flags in trial design before investing millions
• Monitor competitive landscape and market opportunities
• Time exits and follow-on investments based on trial milestones
• Support due diligence with expert medical review

Generate alpha by trading on clinical trial predictions before the market reacts. Leverage our AI-powered insights to build long/short strategies around biotech catalysts.

• Predict trial outcomes weeks before data readouts
• Build event-driven strategies around FDA catalysts
• Real-time alerts on trial updates and regulatory changes
• Quantitative risk scoring for portfolio optimization
• API integration for automated trading strategies

Improve trial success rates by identifying design flaws early and benchmarking against competitor programs. Make go/no-go decisions with confidence backed by AI and expert medical review.

• Validate trial design before committing $100M+ budgets
• Benchmark against competitor trials in the same indication
• Identify safety signals and enrollment challenges early
• Optimize endpoint selection and patient population
• Support licensing and partnership negotiations

Differentiate your CRO by offering AI-powered trial intelligence to pharma clients. Improve trial design recommendations and demonstrate value through predictive analytics.

• Provide value-added services beyond traditional CRO offerings
• Improve trial feasibility assessments with AI insights
• Predict enrollment challenges and site selection issues
• Support protocol optimization and regulatory strategy
• Win more business with data-driven proposals

Access institutional-grade clinical trial intelligence previously available only to hedge funds and VCs. Make informed decisions about biotech stocks with confidence.

• Understand trial success probability before investing
• Get alerts on upcoming data readouts and FDA decisions
• Learn from expert medical review and analysis
• Avoid common pitfalls in biotech investing
• Build a diversified biotech portfolio with confidence